SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-17
👔
CORCEPT THERAPEUTICS INC
@CORT_InsiderForm 4 Filing: Mokari Atabak Sells $4.4M of $CORT
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
CORCEPT THERAPEUTICS INC
Ticker: $CORT
Transaction Value
$4.4M
Price/Share: $54.63
transaction date
2026-07-15
Shares: 80,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Mokari Atabak, holds the title of Chief Financial Officer at CORCEPT THERAPEUTICS INC.
On 2026-07-15, the insider transacted 80,000 shares.The shares were transacted at a weighted average price of $54.63 per share, resulting in a total market-relevant value of $4.4M.
Executive Summary Summary
Mokari Atabak (Chief Financial Officer) sold $4.4M of $CORT
Post-Transaction Position: 19,751 shares
SEC Accession No: 0001193125-26-308058 (CIK: 1678419)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.